Responses
Regular and young investigator award abstracts
Immuno-conjugates and chimeric molecules
622 PD-L1 is a potential predictive biomarker for response to RM-1929 treatment in recurrent head and neck squamous cell carcinoma patients
Compose a Response to This Article
Other responses
No responses have been published for this article.
